Stephen E Goldstone, MD

Clinical Focus

• Anal Abscess (And Anal Fistula)
• Anal Cancer
• Anal Fissure
• Chlamydia
• Genital Herpes
• Genital Warts
• Gonorrhea
• Hemorrhoid Banding
• Hemorrhoidectomy

Show More

• Anal Abscess (And Anal Fistula)
• Anal Cancer
• Anal Fissure
• Chlamydia
• Genital Herpes
• Genital Warts
• Gonorrhea
• Hemorrhoid Banding
• Hemorrhoidectomy
• Hemorrhoids
• Human Papillomavirus Testing
• Human Papillomavirus Vaccine

Locations

Mount Sinai Doctors - West 23rd Street

420 West 23rd Street, Suite PB, New York, NY, 10011

212-242-6500

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:29

Article:72

Review Article:3

Comment/Debate:2

Letter:11

Editorial:5

Recent Artifacts

• Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
• Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity among Sexually Active Men Enrolled in a Global HPV Vaccine Trial
• Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
• Design of the ANal Cancer/HSIL Outcomes Research study (ANCHOR study): A randomized study to prevent anal cancer among persons living with HIV
• ANCHOR Trial Results Are In: So Where Do We Go From Here?
• What Are We Waiting for? - Start Screening High-risk Individuals for Anal Cancer Now
• High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus
• Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies
• Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living with HIV
• Working to prevent anal cancer through innovation

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Goldstone during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.